[{"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-001", "question": "A 28-year-old male with a history of opioid use disorder presents with syncope. He admits to taking 'massive doses' of an over-the-counter anti-diarrheal medication to manage withdrawal symptoms. ECG shows sinus bradycardia at 45 bpm, a QTc interval of 680 ms, and intermittent broad-complex beats. He is hemodynamically stable but lethargic. Magnesium sulfate 2g IV is administered without change in the rhythm. Which of the following is the most appropriate next step in management?", "options": ["Option A: IV Amiodarone infusion", "Option B: IV Isoproterenol infusion", "Option C: IV Physostigmine", "Option D: Synchronized cardioversion", "Option E: IV Calcium gluconate"], "answer": "B", "answer_index": 1, "explanation": "The patient has loperamide toxicity, which blocks cardiac sodium and potassium channels, causing QTc prolongation and wide-complex dysrhythmias. Unlike congenital Long QT (where isoproterenol is contraindicated), loperamide-induced TdP/QT prolongation is bradycardia-dependent; increasing the heart rate (chemical or electrical overdrive pacing) shortens the QT interval and prevents Torsades de Pointes. Amiodarone prolongs QT and is contraindicated.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The patient’s history suggests misuse of loperamide, an over-the-counter antidiarrheal opioid agonist that can cause cardiotoxicity (QT prolongation, wide-complex arrhythmias) at high doses.  \nHe has marked QTc prolongation (680 ms) and intermittent broad-complex beats, likely torsades de pointes or ventricular ectopy.  \nMagnesium sulfate is first-line for torsades, but rhythm persists.  \nIn refractory torsades with bradycardia or pause-dependent initiation, **isoproterenol** (or pacing) can be used to increase heart rate and shorten QT, suppressing the arrhythmia.  \nAmiodarone can further prolong QT, physostigmine is not indicated here, synchronized cardioversion is for unstable tachyarrhythmias (he is stable), and calcium gluconate is for calcium channel blocker or hyperkalemia toxicity.  \n\nThe answer is B"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-002", "question": "A 4-month-old female presents with failure to thrive, hypotonia, and a history of pyridoxine-responsive seizures. Laboratory evaluation reveals hypercalcemia, hypercalciuria, and a suppressed parathyroid hormone (PTH) level. Skeletal survey demonstrates diffuse demineralization and 'moth-eaten' radiolucencies at the metaphyses. Serum alkaline phosphatase (ALP) is 15 IU/L (Reference: 150-420 IU/L). Which of the following is the definitive treatment for this condition?", "options": ["Option A: High-dose Vitamin D supplementation", "Option B: Recombinant human parathyroid hormone (Teriparatide)", "Option C: Asfotase alfa", "Option D: Pyridoxine (Vitamin B6) monotherapy", "Option E: Bisphosphonate therapy"], "answer": "C", "answer_index": 2, "explanation": "The diagnosis is Hypophosphatasia (HPP), caused by a loss-of-function mutation in the ALPL gene encoding tissue-nonspecific alkaline phosphatase (TNSALP). Low ALP leads to accumulation of inorganic pyrophosphate (an inhibitor of bone mineralization) and pyridoxal-5'-phosphate (causing B6-dependent seizures due to lack of dephosphorylation). Asfotase alfa is the enzyme replacement therapy. Vitamin D and bisphosphonates are contraindicated as they may worsen hypercalcemia and inhibit mineralization further.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The clinical picture describes an infant with failure to thrive, hypotonia, pyridoxine-responsive seizures, hypercalcemia, suppressed PTH, severe hypophosphatasia (very low ALP), and characteristic bone findings (demineralization, \"moth-eaten\" metaphyses).  \n\nHypophosphatasia is caused by mutations in the ALPL gene leading to deficient tissue-nonspecific alkaline phosphatase (TNAP) activity. The definitive treatment for severe perinatal/infantile forms is **asfotase alfa**, a bone-targeted recombinant human TNAP enzyme replacement therapy.  \n\n- Vitamin D supplementation (A) would worsen hypercalcemia.  \n- Teriparatide (B) is not used in hypophosphatasia and is contraindicated in pediatric patients with open growth plates except in specific rare circumstances.  \n- Pyridoxine (D) treats pyridoxine-dependent seizures but does not address the bone disease.  \n- Bisphosphonates (E) are used in high bone turnover conditions, not hypophosphatasia.  \n\nThe answer is C.  \n\n**The answer is (C)**"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-003", "question": "A 68-year-old male presents with recurrent fevers, painful auricular chondritis, pulmonary infiltrates, and macrocytic anemia. He has been treated for 'refractory relapsing polychondritis' without success. Bone marrow biopsy reveals hypercellularity with prominent cytoplasmic vacuoles in myeloid and erythroid precursor cells. Which of the following is the most likely diagnosis?", "options": ["Option A: Myelodysplastic Syndrome (MDS) with excess blasts", "Option B: VEXAS syndrome", "Option C: Sweet syndrome", "Option D: Polyarteritis Nodosa", "Option E: Granulomatosis with Polyangiitis"], "answer": "B", "answer_index": 1, "explanation": "VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome is a recently described disorder caused by somatic mutations in the UBA1 gene. It presents in older men with inflammatory features (chondritis, vasculitis, fevers) and hematologic abnormalities (macrocytic anemia). The pathognomonic finding is vacuoles in myeloid and erythroid precursors in the bone marrow.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The patient’s presentation includes:  \n- Recurrent fevers  \n- Painful auricular chondritis (suggestive of relapsing polychondritis)  \n- Pulmonary infiltrates  \n- Macrocytic anemia  \n- Refractory to usual relapsing polychondritis treatment  \n- Bone marrow biopsy: hypercellularity with prominent cytoplasmic vacuoles in myeloid and erythroid precursors  \n\nThese features, especially the **cytoplasmic vacuoles in myeloid/erythroid precursors** in the bone marrow, are highly characteristic of **VEXAS syndrome** (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic), which is an adult-onset autoinflammatory syndrome caused by a somatic mutation in *UBA1* in myeloid cells. It often presents with treatment-refractory inflammatory symptoms (including polychondritis-like features), hematologic abnormalities, and macrocytic anemia.  \n\nThe answer is (B)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-004", "question": "A 55-year-old female with chronic malnutrition and a history of chronic acetaminophen use for osteoarthritis presents with altered mental status. Arterial blood gas shows pH 7.28, pCO2 28 mmHg, HCO3 12 mEq/L. The anion gap is 24. Lactate is 0.9 mmol/L, serum ketones are negative, and creatinine is 1.1 mg/dL. Toxic alcohol screen is negative. Which of the following is the most appropriate therapeutic intervention?", "options": ["Option A: IV Fomepizole", "Option B: IV Sodium Bicarbonate", "Option C: N-acetylcysteine", "Option D: Hemodialysis", "Option E: Thiamine and Dextrose"], "answer": "C", "answer_index": 2, "explanation": "This patient has high anion gap metabolic acidosis due to 5-oxoproline (pyroglutamic acid) accumulation. This occurs in the setting of glutathione depletion (malnutrition, acetaminophen use), which disrupts the gamma-glutamyl cycle. N-acetylcysteine replenishes glutathione stores, restoring the feedback loop and halting 5-oxoproline production. Fomepizole is for toxic alcohols, which were ruled out.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "Let’s break this down step by step.  \n\n**1. Interpret the ABG**  \npH 7.28 → acidemia  \npCO₂ 28 mmHg → low (normal ~40) → respiratory alkalosis  \nHCO₃⁻ 12 mEq/L → low → metabolic acidosis  \n\n**2. Determine primary disorder**  \nFor metabolic acidosis, expected pCO₂ = 1.5 × HCO₃ + 8 ± 2  \n= 1.5 × 12 + 8 = 18 + 8 = 26 mmHg ± 2 → range 24–28 mmHg.  \nMeasured pCO₂ is 28 mmHg → within range → **pure anion gap metabolic acidosis** with appropriate respiratory compensation.  \n\n**3. Anion gap**  \nAG = Na – (Cl + HCO₃) = given as 24 (elevated, normal ~10–12).  \n\n**4. Differential for high AG metabolic acidosis**  \nMnemonic: **GOLD MARK** or **MUDPILES**  \n- Methanol/Ethylene glycol → toxic alcohol screen negative → not this.  \n- Uremia → creatinine 1.1 mg/dL → not uremic acidosis.  \n- DKA → ketones negative → not this.  \n- Propylene glycol, Iron, Isoniazid, Lactic acidosis → lactate 0.9 → not lactic acidosis.  \n- Salicylates → not mentioned, but possible.  \n- **Acetaminophen** → chronic use → can cause **5-oxoproline (pyroglutamic acid) acidosis** in chronic malnutrition (especially females, chronic acetaminophen use, glutathione depletion).  \n\n**5. Clinical clues**  \nChronic malnutrition → low glutathione stores.  \nChronic acetaminophen → depletes glutathione, leads to accumulation of 5-oxoproline → high AG metabolic acidosis, normal lactate, negative ketones, negative toxic alcohols.  \n\n**6. Treatment for 5-oxoproline acidosis**  \nStop acetaminophen, supportive care, possibly **N-acetylcysteine** to replenish glutathione.  \n\n**7. Match to options**  \nA. Fomepizole → for toxic alcohols → not indicated.  \nB. Sodium bicarbonate → could be considered in severe acidosis, but not specific first-line therapy here; question asks “most appropriate therapeutic intervention” given likely cause.  \nC. N-acetylcysteine → correct for suspected 5-oxoproline acidosis from chronic acetaminophen.  \nD. Hemodialysis → not indicated here (no toxic alcohol, pH not extremely low, renal function okay).  \nE. Thiamine and dextrose → for suspected Wernicke’s or alcohol-related, not best here.  \n\nGiven presentation, NAC is both diagnostic (if suspected) and therapeutic.  \n\n**The answer is (C)**  \n\nThe answer is (C)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-005", "question": "A 32-year-old female presents with amenorrhea and galactorrhea. MRI reveals a 4.5 cm pituitary macroadenoma with invasion into the cavernous sinus. Visual fields are intact. Serum prolactin is reported as 145 ng/mL (Reference: <25 ng/mL). Which of the following is the most appropriate next step in management?", "options": ["Option A: Referral for transsphenoidal resection", "Option B: Stereotactic radiosurgery", "Option C: Measurement of prolactin in diluted serum", "Option D: Octreotide scintigraphy", "Option E: Bilateral inferior petrosal sinus sampling"], "answer": "C", "answer_index": 2, "explanation": "A 4.5 cm prolactinoma should typically produce prolactin levels >1,000-10,000 ng/mL. A mildly elevated level in the setting of a giant adenoma suggests the 'Hook Effect,' where excessive antigen saturates the assay antibodies, preventing sandwich formation and leading to a falsely low result. Diluting the sample (1:100) reveals the true elevated value. Confirming a prolactinoma is crucial because dopamine agonists (cabergoline) are the first-line treatment, not surgery.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The patient has a large pituitary macroadenoma (>1 cm) with cavernous sinus invasion, but the prolactin level is only moderately elevated (145 ng/mL). In large tumors, such a prolactin level is disproportionately low and suggests the possibility of the “hook effect,” where very high prolactin levels can saturate the assay antibodies, leading to an artifactually low measurement. Diluting the serum sample would reveal the true, much higher prolactin level, which would confirm a prolactinoma and indicate that dopamine agonist therapy (e.g., cabergoline) is the first-line treatment, not surgery.  \n\nThe answer is (C)."}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-006", "question": "A 60-year-old male with a history of radiation therapy for Hodgkin lymphoma presents with signs of cardiac tamponade. Pericardiocentesis is performed, draining 800 mL of bloody fluid. Following drainage, the intrapericardial pressure drops to 0 mmHg, but the right atrial pressure remains elevated at 18 mmHg with a prominent y-descent that was previously absent. Which of the following is the most likely diagnosis?", "options": ["Option A: Incomplete drainage of the effusion", "Option B: Effusive-constrictive pericarditis", "Option C: Right ventricular infarction", "Option D: Pulmonary embolism", "Option E: Flash pulmonary edema"], "answer": "B", "answer_index": 1, "explanation": "Effusive-constrictive pericarditis is characterized by concurrent tamponade and constriction. The visceral pericardium is thickened and constrictive. Initially, the effusion masks the constriction (tamponade physiology: blunted y-descent). After drainage, the tamponade resolves, but the underlying constriction becomes manifest (elevated RA pressure with prominent y-descent). Treatment requires visceral pericardiectomy.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The patient has a history of radiation therapy (a known cause of pericardial disease) and presented with tamponade. After pericardiocentesis, the intrapericardial pressure normalizes (0 mmHg), but right atrial pressure remains elevated with a prominent y-descent. This hemodynamic pattern—persistent elevation of right atrial pressure with a prominent y-descent after pericardial fluid drainage—is classic for **effusive-constrictive pericarditis**, where there is both a pericardial effusion (causing tamponade) and underlying constrictive physiology from visceral pericardial involvement.  \n\nThe answer is (B)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-007", "question": "A 65-year-old male is admitted to the ICU for sedation and mechanical ventilation. On day 3 of a continuous propofol infusion, he develops new Right Bundle Branch Block with coved ST-segment elevation in leads V1-V3. Labs reveal severe metabolic acidosis (pH 7.18), Lactate 9 mmol/L, and CK 8,000 U/L. Echocardiogram shows new global hypokinesis. Which of the following is the most likely diagnosis?", "options": ["Option A: Acute Anterior ST-Elevation MI", "Option B: Massive Pulmonary Embolism", "Option C: Propofol Infusion Syndrome", "Option D: Brugada Syndrome unmasked by fever", "Option E: Septic Cardiomyopathy"], "answer": "C", "answer_index": 2, "explanation": "Propofol Infusion Syndrome (PRIS) is a rare but lethal complication of high-dose/long-duration propofol. It causes mitochondrial failure leading to rhabdomyolysis, metabolic acidosis, heart failure, and characteristic ECG changes (often Brugada-like pattern: RBBB with coved ST elevation). Immediate cessation of propofol and supportive care is required.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The patient is on a continuous propofol infusion and develops signs of severe metabolic acidosis, elevated lactate, rhabdomyolysis (high CK), new right bundle branch block with coved ST elevation in V1–V3 (suggestive of Brugada pattern), and global hypokinesis.  \nThis constellation is characteristic of **propofol infusion syndrome** (PRIS), a rare but life‑threatening complication of prolonged, high‑dose propofol infusion, especially in critically ill patients.  \n\nOther options are less likely:  \n- Acute anterior STEMI would typically show ST elevation in anterior leads but not necessarily a Brugada‑type pattern and is not directly linked to propofol infusion.  \n- Massive PE could cause right heart strain but not the metabolic profile and Brugada‑type ECG changes seen here.  \n- Brugada syndrome unmasked by fever could explain the ECG but not the severe acidosis, high lactate, rhabdomyolysis, and global hypokinesis in this setting.  \n- Septic cardiomyopathy might cause global hypokinesis but not the specific ECG pattern and metabolic disturbances seen with PRIS.  \n\nThe answer is (C)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-008", "question": "A 58-year-old male with dyslipidemia develops proximal muscle weakness and myalgias. His CK is 8,500 U/L. Atorvastatin is discontinued. Two months later, his weakness has progressed, and CK remains elevated at 9,200 U/L. Muscle biopsy shows necrotizing myopathy with minimal inflammation. Testing for anti-HMGCR antibodies is positive. Which of the following is the most appropriate management?", "options": ["Option A: Switch to Rosuvastatin", "Option B: Initiate Coenzyme Q10 supplementation", "Option C: Initiate IVIG and/or systemic immunosuppression", "Option D: Observation for spontaneous resolution", "Option E: Dantrolene sodium"], "answer": "C", "answer_index": 2, "explanation": "This patient has Statin-Associated Autoimmune Myopathy (SAAM), specifically anti-HMGCR positive necrotizing myopathy. Unlike self-limited statin myotoxicity, this is an autoimmune process that progresses despite statin cessation. It requires aggressive immunosuppression (steroids, IVIG, Rituximab, or Methotrexate) to prevent permanent muscle loss.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The patient has statin-associated necrotizing autoimmune myopathy (anti-HMGCR myopathy), which is an autoimmune condition that persists and often progresses despite statin discontinuation.  \nTreatment requires immunosuppression, not just stopping the statin or supportive measures.  \n\nThe answer is (C)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-009", "question": "A 2-week-old XX infant presents with ambiguous genitalia (virilization). Vital signs reveal a blood pressure of 96/60 mmHg (hypertensive for age). Laboratory evaluation shows Sodium 136 mEq/L and Potassium 2.9 mEq/L. 17-hydroxyprogesterone is elevated. Which of the following enzyme deficiencies is the most likely cause?", "options": ["Option A: 21-hydroxylase deficiency", "Option B: 11-beta-hydroxylase deficiency", "Option C: 17-alpha-hydroxylase deficiency", "Option D: 3-beta-hydroxysteroid dehydrogenase deficiency", "Option E: P450 oxidoreductase deficiency"], "answer": "B", "answer_index": 1, "explanation": "Congenital Adrenal Hyperplasia due to 11-beta-hydroxylase deficiency blocks cortisol synthesis, shunting precursors to androgens (causing virilization in females) and accumulating 11-deoxycorticosterone (DOC). DOC is a potent mineralocorticoid, leading to salt retention, hypertension, and hypokalemia. This distinguishes it from the more common 21-hydroxylase deficiency, which causes salt-wasting (hypotension, hyperkalemia).", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The infant has ambiguous genitalia with virilization (indicating androgen excess), hypertension, hypokalemia, and elevated 17-hydroxyprogesterone.  \n\n- **21-hydroxylase deficiency** causes virilization and elevated 17-hydroxyprogesterone, but typically leads to salt-wasting (hyponatremia, hyperkalemia) or simple virilizing forms, not hypertension with hypokalemia.  \n- **11-beta-hydroxylase deficiency** causes virilization, elevated 17-hydroxyprogesterone, and hypertension with hypokalemia due to accumulation of deoxycorticosterone (a mineralocorticoid).  \n- **17-alpha-hydroxylase deficiency** causes hypertension and hypokalemia but results in undervirilization (female external genitalia) in genetic males and no virilization in females, not virilization.  \n- **3-beta-hydroxysteroid dehydrogenase deficiency** usually causes salt-wasting and incomplete virilization in males, not hypertension/hypokalemia.  \n- **P450 oxidoreductase deficiency** can cause ambiguous genitalia but is not typically associated with hypertension/hypokalemia.  \n\nThe combination of virilization, hypertension, hypokalemia, and elevated 17-hydroxyprogesterone points to **11-beta-hydroxylase deficiency**.  \n\n**The answer is (B)**"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-010", "question": "A 45-year-old male on chronic amiodarone therapy for atrial fibrillation presents with weight loss and palpitations. TSH is <0.01 mIU/L and Free T4 is elevated. He has no neck pain. Thyroid ultrasound with color flow Doppler reveals an absence of vascularity within the thyroid parenchyma. Which of the following is the most appropriate initial treatment?", "options": ["Option A: Methimazole", "Option B: Propylthiouracil", "Option C: Prednisone", "Option D: Radioactive Iodine ablation", "Option E: Potassium Perchlorate"], "answer": "C", "answer_index": 2, "explanation": "This is Type 2 Amiodarone-Induced Thyrotoxicosis (AIT), which is a destructive thyroiditis caused by direct cytotoxic effects of the drug. The key differentiator from Type 1 AIT (Jod-Basedow/iodine-induced synthesis) is the Doppler flow: Type 1 has increased vascularity, while Type 2 has absent vascularity. Type 2 is treated with high-dose glucocorticoids. Thionamides (Methimazole) are ineffective for destructive thyroiditis.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The patient on amiodarone with thyrotoxicosis, low TSH, elevated free T4, and an ultrasound showing **absence of vascularity** in the thyroid parenchyma is consistent with **amiodarone-induced destructive thyroiditis** (Type 2).  \nIn Type 2 amiodarone-induced thyroiditis, there is a destructive process with release of preformed hormone, not increased synthesis. Antithyroid drugs (methimazole, PTU) are ineffective because they block new hormone synthesis.  \nThe first-line treatment is **glucocorticoids** (e.g., prednisone) to reduce inflammation and the destructive process.  \nRadioactive iodine is not effective because uptake is very low in destructive thyroiditis. Potassium perchlorate is rarely used and not first-line.  \n\n**The answer is C**"}]